Literature DB >> 7473886

Platelet-derived growth factor is a survival factor for PSA-NCAM+ oligodendrocyte pre-progenitor cells.

J B Grinspan1, B Franceschini.   

Abstract

Mature oligodendroglia, which synthesize and express lipids and proteins characteristic of myelin, are generated from precursor cells which are formed in germinal matrix, then migrate widely through the neuraxis. We now demonstrate that these precursor cells can be recognized at a very early stage by their surface expression of polysialylated neural cell adhesion molecules (PSA-NCAM), and only later bind anti-ganglioside antibodies that had previously been used to recognize "O-2A" oligodendroglial precursor cells. PSA-NCAM expression by these cells is likely to be of functional significance, since a recent study demonstrated that O-2A cells become immobile when stripped of PSA-NCAM. Platelet-derived growth factor (PDGF) proved to be a survival factor for these PSA-NCAM+cells, and in a defined medium, PDGF was sufficient to ensure maturation of immunopurified PSA-NCAM+cells to oligodendroglia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473886     DOI: 10.1002/jnr.490410414

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  27 in total

1.  BMP signaling mutant mice exhibit glial cell maturation defects.

Authors:  Jill See; Polina Mamontov; Kyung Ahn; Lara Wine-Lee; E Bryan Crenshaw; Judith B Grinspan
Journal:  Mol Cell Neurosci       Date:  2007-02-23       Impact factor: 4.314

Review 2.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

3.  Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.

Authors:  Brigid K Jensen; Hubert Monnerie; Maggie V Mannell; Patrick J Gannon; Cagla Akay Espinoza; Michelle A Erickson; Annadora J Bruce-Keller; Benjamin B Gelman; Lisa A Briand; R Christopher Pierce; Kelly L Jordan-Sciutto; Judith B Grinspan
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

4.  Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4.

Authors:  Mary V Reid; Kaitlin A Murray; Eric D Marsh; Jeffrey A Golden; Rebecca A Simmons; Judith B Grinspan
Journal:  J Neuropathol Exp Neurol       Date:  2012-07       Impact factor: 3.685

5.  Platelet-derived growth factor promotes repair of chronically demyelinated white matter.

Authors:  Adam C Vana; Nicole C Flint; Norah E Harwood; Tuan Q Le; Marcus Fruttiger; Regina C Armstrong
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

6.  Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.

Authors:  Chang-Jiang Guo; Steven D Douglas; Zhiyong Gao; Bryan A Wolf; Judith Grinspan; Jian-Ping Lai; Eric Riedel; Wen-Zhe Ho
Journal:  Glia       Date:  2004-11-15       Impact factor: 7.452

Review 7.  The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2009-08-29       Impact factor: 5.590

8.  Crucial role of the local micro-environment in fate decision of neonatal rat NG2 progenitors.

Authors:  J Sypecka; A Sarnowska; K Domanska-Janik
Journal:  Cell Prolif       Date:  2009-07-09       Impact factor: 6.831

9.  Beta4 tubulin identifies a primitive cell source for oligodendrocytes in the mammalian brain.

Authors:  Chuanshen Wu; Ansi Chang; Maria C Smith; Roy Won; Xinghua Yin; Susan M Staugaitis; Dimitri Agamanolis; Grahame J Kidd; Robert H Miller; Bruce D Trapp
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

10.  Oxidative stress disrupts oligodendrocyte maturation.

Authors:  Heather Morein French; Mary Reid; Polina Mamontov; Rebecca A Simmons; Judith B Grinspan
Journal:  J Neurosci Res       Date:  2009-11-01       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.